Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clonal Hematopoiesis of Indeterminate Potential (CHIP)”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT07362966
What this trial is testing

Effect of Colchicine on Progression of Coronary Atherosclerosis in Patients With TET2-CHIP Variant

Who this might be right for
ColchicineCoronary Atherosclerosis ManagementClonal Hematopoiesis of Indeterminate Potential
Shenyang Northern Hospital 120
Not applicableUnknownNCT05828888
What this trial is testing

CHIP in Endothelial Dysfunction Associated With HEpEF

Who this might be right for
Heart Failure With Preserved Ejection Fraction
University Hospital, Bordeaux 80
Not applicableLooking for participantsNCT05246813
What this trial is testing

Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)

Who this might be right for
OsteoporosisOsteoarthritis, HipHip Fractures+2 more
Imelda Hospital, Bonheiden 24
Not applicableStudy completedNCT04987268
What this trial is testing

CHIP and Residual Cardiovascular Event Tendency After Smoking Cessation

Who this might be right for
ACSClonal Hematopoiesis of Indeterminate PotentialSmoking Cessation
Shenyang Northern Hospital 1,029
Testing effectiveness (Phase 2)Study completedNCT06097663
What this trial is testing

Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)

Who this might be right for
Coronary Heart DiseaseClonal Hematopoiesis of Indeterminate Potential (CHIP)
Novartis Pharmaceuticals 31
Not applicableLooking for participantsNCT06785077
What this trial is testing

Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors

Who this might be right for
Leukemia, Myeloid, AcuteMyeloid DysplasiaOvarian Epithelial Cancer
European Institute of Oncology 157
Not applicableLooking for participantsNCT06870760
What this trial is testing

Pre-malignant States to Hematologic Malignancies in Firefighters

Who this might be right for
Clonal Hematopoiesis of Indeterminate PotentialMonoclonal GammopathyNon Hodgkin Lymphoma+3 more
Wake Forest University Health Sciences 300
Not applicableLooking for participantsNCT04102423
What this trial is testing

CHIP/CCUS Natural History Protocol

Who this might be right for
Clonal Hematopoiesis of Indeterminate PotentialClonal Cytopenia of Undetermined Significance
National Heart, Lung, and Blood Institute (NHLBI) 306
Not applicableLooking for participantsNCT04689750
What this trial is testing

Donor CHIP and Allogeneic HSCT Outcome

Who this might be right for
Clonal Hematopoiesis
The University of Hong Kong 850
Not applicableLooking for participantsNCT04053439
What this trial is testing

Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications

Who this might be right for
LymphomaChemotherapeutic Toxicity
Sunnybrook Health Sciences Centre 188